Insiders who reported open-market trades in the last 12 months at the companies Melissa M. Tomkiel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Amir Cohen - $410K in SRTA purchases and sales in the last 12 months
William A. Heyburn - $186K in SRTA purchases and sales in the last 12 months
Reginald Love - $125K in SRTA purchases and sales in the last 12 months
Scott M. Wunsch - $33K in SRTA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Melissa M. Tomkiel is a corporate insider, tracked as Co-CEO and General Counsel, Director of Strata Critical Medical, Inc. (SRTA). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Melissa M. Tomkiel submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Melissa M. Tomkiel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.18M) across all tracked filings.
Melissa M. Tomkiel is Co-CEO and General Counsel, Director of Strata Critical Medical, Inc. (SRTA). 17 SEC Form 4 filings on record going back to 2024, most recently on 25 September 2026. Most recent open-market trade: sold $175K of SRTA on 10 June 2026. Lifetime open-market sales: $1.18M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Melissa M. Tomkiel.
InsiderAlpha's records for Melissa M. Tomkiel go back to 2024: 17 primary Form 4 filings, an average of 5.7 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
